[ad_1]

Company Logo

Dublin, Nov. 02, 2022 (GLOBE NEWSWIRE) — The “Cell & Gene Therapy Manufacturing Services Market Analysis by Type, by Indication, by Application, End user and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s providing.

The cell & gene remedy manufacturing companies market dimension is estimated to be USD 8.4 billion in 2021 and is predicted to witness a CAGR of 14.56% in the course of the forecast interval 2022-2029. The excessive charge of most cancers and different goal illnesses, rising investments in pharmaceutical R&D, investments in superior applied sciences by CDMOs, and growing partnerships and contracts between pharmaceutical firms and CDMOs are a few of the key drivers for the market development.

However, growing operational prices associated to cell and gene remedy manufacturing are anticipated to restrain the market development.

By Type

Based on kind, the market is bifurcated into gene remedy and cell remedy. In 2021, cell remedy section accounted for the very best income share as a result of improvement of recent applied sciences and product improvements which have allowed a wide range of cells, together with mesenchymal stem cells, dendritic cells, and T-cells, hematopoietic stem cells (HSC), pure killer cells, to deal with diseases and illnesses.

By Indication

On the premise of Indication, the market is segregated into central nervous system problems, ophthalmology illnesses, cardiovascular illnesses, infectious illnesses, orthopaedic illnesses, oncology illnesses, and others. In 2021, the infectious illnesses section accounted for the biggest income share owing to the growth of cell remedy scientific trials due to the rise in infectious sickness prevalence.

By Application

Based on Application, the market is bifurcated into business manufacturing and scientific manufacturing. In 2021, the scientific manufacturing section accounted for the biggest income share as a result of rising variety of gene remedy scientific trials and the consistently increasing world pipeline of cell and gene therapies.

By End person

On the premise of finish person, the market is categorized into tutorial & analysis institutes and pharmaceutical & biotechnological firms. In 2021, the educational and analysis institutes section accounted for the very best share owing to growing authorities funding for analysis, and rising spending within the R&D sector in life sciences.

Regional Markets

In 2021, North America area accounted for the very best income within the cell & gene remedy manufacturing companies market and is predicted to take care of its dominance in the course of the forecast interval. This is attributed to rising prevalence of most cancers and growing analysis effort in most cancers and stem cells, and important funding in biopharmaceutical analysis and improvement are fuelling market development. Furthermore, rising funding in pharmaceutical analysis and improvement is hastening regional market growth.

Segmentation: Cell & Gene Therapy Manufacturing Services Market Report 2021-2029
By Type (Revenue, USD Billion)

Story continues

By Indication (Revenue, USD Billion)

By Application (Revenue, USD Billion)

Commercial Manufacturing

Clinical Manufacturing

By End person (Revenue, USD Billion)

By Region (Revenue, USD Billion)
North America

Europe

Germany

France

UK

Spain

Italy

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

Middle East & Africa

South Africa

GCC

Rest of MEA

Key Topics Covered:

1. Research Methodology

2. Introduction: Cell & Gene Therapy Manufacturing Services

3. Executive Summary

4. Market Dynamics

5. Market Environment Analysis

6. COVID-19 Impact Analysis: Cell & Gene Therapy Manufacturing Services Market

7. Market Analysis by Type

8. Market Analysis by Indication

9. Market Analysis by Application

10. Market Analysis by End person

11. Regional Market Analysis

12. North America Cell & Gene Therapy Manufacturing Services Market

13. Europe Cell & Gene Therapy Manufacturing Services Market

14. Asia Pacific Cell & Gene Therapy Manufacturing Services Market

15. Latin America Cell & Gene Therapy Manufacturing Services Market

16. MEA Cell & Gene Therapy Manufacturing Services Market

17. Competitor Analysis

18. Company Profiles

19. Conclusion & Recommendations

Companies Mentioned

Thermo Fisher Scientific Inc. (US)

Merck KGaA (Germany)

Charles River Laboratories (US)

Lonza (Switzerland)

Catalent Inc. (US)

WuXi AppTec (China)

Takara Bio Inc. (Japan)

NIKON CORPORATION (Japan)

FUJIFILM Holdings Corporation (Japan)

F. Hoffmann-La Roche Ltd. (Switzerland)

Oxford Biomedica plc (UK)

Cell and Gene Therapy Catapult (UK)

The Discovery Labs LLC (US)

RoslinCT (Scotland)

JRS PHARMA (Germany)

FinVector (Finland)

ABL Inc. (US)

Resilience (US)

BioCentriq (US)

Porton Biopharma Limited (England)

elyn Biosciences (US)

Commercializing Living Therapies (Canada)

Vibalogics (US)

Anemocyte Srl (Italy)

ElevateBio (US).

For extra details about this report go to https://www.researchandmarkets.com/r/v0yca5

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

[ad_2]

Source link

#Cell #Gene #Therapy #Manufacturing #Services #Market #Grow #Annually

By Seth A. Dunbar

Seth Dunbar leads clinical research study operations and quality & compliance. He is experienced working with teams to help drug sponsors better leverage eSource data. With 10+ years of experience Seth brings expertise developing eClinical services that integrate data and technology to help companies optimise study execution.

Leave a Reply

Your email address will not be published. Required fields are marked *